Piramal Pharma Ltd (Mumbai) (PPLPHARMA) Stock Price & News

PPLPHARMA:NSE

Piramal Pharma Ltd (Mumbai)

₹241.41

-1.49%

(-3.66) 1D

Nov 13, 12:22:39 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Oct 28, 2026

Fiscal period

Q2 2027

₹0.04 / -₹0.38

+110.57%beat

Revenue / Est. (INR)

26.17B / 23.58B

+11.00%beat

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	21.40B	27.52B	22.70B	26.17B
Cost of goods sold	7.86B	13.95B	8.52B	9.06B
Cost of revenue	7.86B	13.95B	8.52B	9.06B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.00B	8.19B	6.76B	7.14B
Operating expense	13.71B	11.09B	14.46B	15.95B
Total operating expenses	21.57B	25.04B	22.98B	25.01B
Operating income	-170.10M	2.47B	-283.50M	1.16B
Other non operating income	432.40M	-977.90M	894.10M	359.30M
EBT including unusual items	-938.60M	430.00M	-74.60M	816.30M
EBT excluding unusual items	-527.50M	1.40B	-74.60M	816.30M
Income tax expense	423.30M	518.30M	619.30M	766.00M
Effective tax rate	-45.10%	120.53%	-830.16%	93.84%
Other operating expenses	5.58B	723.30M	5.47B	6.48B
Net income	-1.36B	-88.30M	-693.90M	55.80M
Net profit margin	-6.36%	-0.32%	-3.06%	0.21%
Earnings per share	-0.72	1.32	-0.52	0.04
Interest and investment income	-	70.70M	-	-
Interest expense	-892.40M	-805.40M	-880.80M	-876.30M
Net interest expenses	-892.40M	-734.70M	-880.80M	-876.30M
Depreciation and amortization charges	2.13B	2.18B	2.24B	2.33B
EBITDA	1.68B	4.32B	1.57B	3.29B
Gain or loss from assets sale	-	-	-	-

Finance